In The News
Stay informed with the latest research breakthroughs, treatment updates, and community stories related to Parkinson’s disease.
Fighting Parkinson’s Disease with Exercise and Diet
Johns Hopkins Medicine Doing your best to remain healthy and strong is key for everyone with Parkinson’s disease. Research has shown that following certain lifestyle modifications can help you accomplish two important goals: Better control symptoms. Slow progression...
Study shows Parkinson’s affects brain circuits in different ways
Low dopamine levels can produce opposite changes Written by Marisa Horak, MS | July 31, 2026 Parkinson's disease causes varied, even opposite, changes in brain circuits due to low dopamine levels. Low dopamine levels correlate with motor symptoms; cognitive issues are...
FDA backs faster development path for Parkinson’s cell therapy
Sasineprocel gets regenerative medicine advanced therapy designation Written by Marisa Horak, MS | Aug. 3, 2026 FDA granted RMAT designation to sasineprocel, a cell therapy for Parkinson's disease. This therapy uses engineered stem cells to replace lost dopaminergic...
The Power of UConn Collaborating for Parkinson’s Disease Patients
July 29, 2026 | Lauren Woods UConn Health Parkinson's disease patients like Jose Figueroa are experiencing the power of a UConn-made protein shake being tested by the UConn research team in an FDA clinical study. Jose Figueroa, 66, of New Britain is “so grateful” for...
Turmeric compound may protect motor function in Parkinson’s mouse model
Preclinical study links curcumin’s effects to cellular recycling pathways Written by Marisa Horak, MS | Aug. 4, 2026 Curcumin pretreatment helped protect motor function in a Parkinson’s mouse model. It activated autophagy and reduced cuproptosis, a copper-dependent...
Storytelling language sheds light on Parkinson’s memory issues
Language analysis outperforms standard tests in spotting cognitive issues Written by Marisa Horak, MS | July 28, 2026 Language analysis of storytelling detected Parkinson's cognitive issues better than standard tests. Parkinson's patients showed reduced storytelling...
Training app paired with levodopa eases Parkinson’s symptoms
Hybridopa program leads to changes in brain networks involved in movement Written by Michela Luciano, PhD | July 28, 2026 Hybridopa, a digital app combined with levodopa, eased Parkinson's motor symptoms. This therapy induced structural and functional brain changes,...
Alzheimer’s may play limited role in early Parkinson’s cognitive problems
Study found no clear p-tau217 link in patients without dementia Written by Michela Luciano, PhD | July 29, 2026 The Alzheimer’s marker p-tau217 was not clearly linked to early cognitive problems in people with Parkinson’s who did not have dementia. Early cognitive...
Blood marker may help detect cognitive decline in Parkinson’s: Study
Specific ceramide ratio and inflammation combine to signal risk Written by Michela Luciano, PhD | July 30, 2026 A specific blood ceramide ratio is linked to worsening cognitive decline in Parkinson's disease. Higher levels of this ratio predict poorer cognitive...
US biotech secures $150M to develop potential treatments for Parkinson’s
1 therapy, bevemipretide, was shown to ease brain inflammation in mice Written by Andrea Lobo | July 16, 2026 Massachusetts-based biotech Mighty Therapeutics has raised $150 million to advance treatments for Parkinson's and other diseases. One drug in its pipeline is...